Design and Motion Control of a Lower Limb Robotic Exoskeleton

Abstract

This chapter presents the results of research work on design, actuator selection and motion control of a lower extremity exoskeleton developed to provide legged mobility to spinal cord injured (SCI) individuals. The exoskeleton has two degrees of freedom per leg. Hip and knee joints are actuated in the sagittal plane by using DC servomotors. Additional effort supplied by user's arms through crutches is defined as user support rate (USR). Experimentally determined USR values are considered in actuator torque computations for achieving a realistic actuator selection. A custom-embedded system is used to control exoskeleton. Reference joint trajectories are determined by using clinical gait analysis (CGA). Three-loop cascade controllers with current, velocity and position feedback are designed for controlling the joint motions of the exoskeleton. A non-linear ARX model is used to determine controller parameters. Overall performance and an assistive effect of WSE-2 are experimentally investigated by conducting tests with a paraplegic patient with T10 complete injury.

Arduino Based Simulation and Mathematical Modelling for Lower Limb Exoskeleton

“…Connecting Cables are linked with sensor placement. An IMU is mounted on each joint of the exoskeleton which are securely attached and aligned with the axis of rotation of the joint [17].…”

Role of nano-biomechanics in brain metastasis formation and amyotrophic lateral sclerosis

“…The origin of ALS in 5-10% of the cases is familial (fALS), while the rest of the patients diagnosed with ALS have a sporadic disease (sALS) [84]. However, the two are clinically undistinguishable from each other [85]. The survival time after first symptoms for 50% of the patients is below 30 months, while only 20% of patients survive after 5 years and a small percentage live for more than 10 years [86].…”

“…The scientific interest to investigate the disease started to raise in the 90"s, after some new insights in the glutamate neurotransmitter system and the discovery of genes linked to the development of familial ALS [84]. Since then several genetic studies have dealt with the ALS, revealing the involvement of mutations in the genes of SOD1, TARDBP and FUS, but also a genetic defect in a noncoding nucleotide sequence was associated with ALS [85].…”

“…Although for a long time ALS was considered merely as a motor neuron disease, due to recent findings it is now related to a range of neurological disorders [83]. Despite the numerous findings, that revealed several potential pathogenic mechanisms and the involvement of different cell types in the development of ALS, its etiology remains elusive [85].…”

“…According to recent findings motor neuron degeneration in ALS, instead of being the result of only neuronal autonomous cell death, is rather a more complex mechanism accompanying neurotoxic inflammatory processes [85], where T cells play an important role. This led us to investigate motor neuron -T cell interactions by monitoring short term adhesion forces on primary motoneurons probed both by wild-type and SOD1 G93A derived T cells immobilized on a tip-less AFM cantilever.…”